Conferences and symposiums Second Scientific Symposium by the Swedish FTD Initiative

15-04-2021 9:00 am - 4:00 pm Add to iCal
Online Online via Zoom

Welcome to the Swedish FTD Initiative Scientific Symposium 2021 on 15 April 2021, between 09:00 and 16:00. The symposium will include an exciting update for clinicians and researchers with an interested in FTD.

Join the digital meeting

Via Zoom link

Screen sharing is enabled for all participants.

Some requests for the online meeting

  • Please mute your audio.
  • Please have your video turned on so we can provide a virtual audience for the speakers as well as see everyone. 
  • Please display your name in the Zoom-window
  • Questions:  please raise your “digital hand” in Zoom or type into the chat box to let us know if you have a question/comment. Questions will be addressed at the end of the talks.

Topics all relate to FTD and include the recently published SweFTDI guidelines for clinical assessment of, differential diagnosis to primary psychiatric disease, an update on the ongoing and planned clinical trials in FTD, a presentation of the research participant’s perspective, proteomics for biomarker discovery in FTD as well as ongoing research in SweFTDI. See attached program.

09:00-09:10
Welcome and introduction

Caroline Graff, Karolinska Institutet, Swedish FTD Initiative

09:10-09:50
FTD diagnostic criteria and the SweFTDI clinical guidelines available at frontallobsdemens.se

Lena Kilander, Uppsala University Hospital

09:50-10:30
Psychiatric diseases and FTD, a differential diagnostic perspective

Yolande Pijnenburg, Amsterdam Univerisity Medical Center, The Nehterlands

10:30-10:40
10 min break
10:40-11:20
Clinical trial design in genetic FTD - lessons from GENFI and the FPI.

Jonathan Rohrer, UCL, London, United Kingdom

11:20-12:00
Using GENFI participant engagement to inform observational reserach and clinical trials

Caroline Greaves, UCL, London, United Kingdom

12:00-12:40
Lunch
12:40-13:20
Proteomics studies to increase our understanding and generate biomarkers for FTD

Charlotte Teunessen, Amsterdam University Medical Center, The Netherlands

13:20-14:00
Neuroimaging in genetic forms of FTD

John C van Swieten, Erasmus Medical Center Rotterdam, The Netherlands

14:00-14:15
Gyrification pattern affects disease expression in frontotemporal dementia

Luke Harper, PhD student, affiliation Clinical Memory Research Unit, Lund University

14:15-14:30
Small affinity proteins targeting FTD

Stefan Ståhl, The Royal Institute of Technology (KTH)

14:30-14:45
Machine learning based evaluation of protein profiles in CSF: a GENFI study

Sofia Bergström, PhD, SciLifeLab KTH

14:45-15:00
15 min break
15:00-15:15
Explorative plasma protein analysis in genetic FTD: a GENFI study

Linn Öijerstedt, PhD student, Karolinska Institutet

15:15-15:30
TBK1 haploinsufficiency result in FTD

Behzad Khoshnood, Postdoc, Karolinska Institutet

15:30-15:45
Functional connectivity of the dorsal and ventral anterior insula in bvFTD

Divya Brundavanam, Postdoc, Karolinska Institutet

15:45-16:00
Final words

Swedish FTD Initiative is a collaboration between Karolinska Institutet, SciLifeLab KTH, The Royal Institute of Technology (KTH) and Karolinska University Hospital, supported by The Schörling Foundation.

Contact

Caroline Graff Professor/specialist physician